Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Tania Balboni"'
Autor:
Lorena Landuzzi, Arianna Palladini, Claudio Ceccarelli, Sofia Asioli, Giordano Nicoletti, Veronica Giusti, Francesca Ruzzi, Marianna L. Ianzano, Laura Scalambra, Roberta Laranga, Tania Balboni, Maddalena Arigoni, Martina Olivero, Raffaele A. Calogero, Carla De Giovanni, Massimiliano Dall’Ora, Enrico Di Oto, Donatella Santini, Maria Pia Foschini, Maria Cristina Cucchi, Simone Zanotti, Mario Taffurelli, Patrizia Nanni, Pier-Luigi Lollini
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract We established patient-derived xenografts (PDX) from human primary breast cancers and studied whether stability or progressive events occurred during long-term in vivo passages (up to 4 years) in severely immunodeficient mice. While most PDX
Externí odkaz:
https://doaj.org/article/59a0895a37d34757859e7e9b853a7ad6
Autor:
Arianna Palladini, Susan Thrane, Christoph M. Janitzek, Jessica Pihl, Stine B. Clemmensen, Willem Adriaan de Jongh, Thomas M. Clausen, Giordano Nicoletti, Lorena Landuzzi, Manuel L. Penichet, Tania Balboni, Marianna L. Ianzano, Veronica Giusti, Thor G. Theander, Morten A. Nielsen, Ali Salanti, Pier-Luigi Lollini, Patrizia Nanni, Adam F. Sander
Publikováno v:
OncoImmunology, Vol 7, Iss 3 (2018)
Overexpression of human epidermal growth factor receptor-2 (HER2) occurs in 20–30% of invasive breast cancers. Monoclonal antibody therapy is effective in treating HER2-driven mammary carcinomas, but its utility is limited by high costs, side effec
Externí odkaz:
https://doaj.org/article/e1b993a0c5c5445cb0c1372cb80b222f
Autor:
Tania Balboni, Claudio Ceccarelli, Maria Pia Foschini, Mario Taffurelli, Veronica Giusti, Maria C. Cucchi, Francesca Ruzzi, Roberta Laranga, Laura Scalambra, Pier Luigi Lollini, Carla De Giovanni, Arianna Palladini, Raffaele Calogero, Simone Zanotti, Marianna L. Ianzano, Enrico Di Oto, Patrizia Nanni, Maddalena Arigoni, Martina Olivero, Giordano Nicoletti, Lorena Landuzzi, Massimiliano Dall'Ora, Donatella Santini, Sofia Asioli
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Scientific Reports
Scientific Reports
We established patient-derived xenografts (PDX) from human primary breast cancers and studied whether stability or progressive events occurred during long-term in vivo passages (up to 4 years) in severely immunodeficient mice. While most PDX showed s
Autor:
Marta F. Fidalgo, Catarina G. Fonseca, Paulo Caldas, Alexandre A. S. F. Raposo, Tania Balboni, Ana R. Grosso, Francisca F. Vasconcelos, Cláudio A. Franco
Gas exchanges are ensured by lung alveoli, which are mainly composed by epithelial alveolar type 1 (AT1), alveolar type 2 (AT2) and capillary endothelial cells (ECs). Alveologenesis starts during late embryonic development and continues after birth a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3e0499e9f5fedb6258479c0092015aa
https://doi.org/10.1101/2022.01.19.476886
https://doi.org/10.1101/2022.01.19.476886
Autor:
Roberta Laranga, Lorena Landuzzi, Marianna L. Ianzano, Manuela Iezzi, Massimiliano Dall'Ora, Donatella Santini, Patrizia Nanni, Veronica Giusti, Enrico Di Oto, Mario Taffurelli, Giordano Nicoletti, Augusto Amici, Alessia Lamolinara, Serenella M. Pupa, Tania Balboni, Arianna Palladini, Claudio Ceccarelli, Sofia Asioli, Pier Luigi Lollini, Elda Tagliabue, Carla De Giovanni
Publikováno v:
Oncotarget
// Arianna Palladini 1, * , Giordano Nicoletti 2, * , Alessia Lamolinara 3, * , Massimiliano Dall’Ora 1, * , Tania Balboni 1 , Marianna L. Ianzano 1 , Roberta Laranga 1 , Lorena Landuzzi 2 , Veronica Giusti 1 , Claudio Ceccarelli 1, 4 , Donatella S
Autor:
Adam F. Sander, Jessica Pihl, Lorena Landuzzi, Pier Luigi Lollini, Ali Salanti, Manuel L. Penichet, Morten Nielsen, Susan Thrane, Thor H. Theander, Veronica Giusti, Thomas Mandel Clausen, Christoph M. Janitzek, Patrizia Nanni, Wilhelm A. de Jongh, Giordano Nicoletti, Stine B. Clemmensen, Tania Balboni, Arianna Palladini, Marianna L. Ianzano
Publikováno v:
Cancer Research. 78:716-716
Overexpression of human epidermal growth factor receptor-2 (HER-2) occurs in about 20% of invasive breast cancers. Anti-HER-2 monoclonal antibody therapy is effective, but its utility is limited by high costs, side effects and development of resistan
Autor:
Arianna Palladini, Maria Pia Foschini, Mario Taffurelli, Marianna L. Ianzano, Sofia Asioli, Tania Balboni, Lorena Landuzzi, Pier Luigi Lollini, Massimiliano Dall'Ora, Donatella Santini, Roberta Laranga, Enrico Di Oto, Giordano Nicoletti, Claudio Ceccarelli, Patrizia Nanni, Carla De Giovanni, Veronica Giusti
Publikováno v:
Cancer Research. 78:216-216
Human tumors are dynamic entities that undergo variation, selection and progression within the patient. How well patient-derived xenografts (PDX) recapitulate tumor dynamics? To investigate these aspects we established a collection of breast cancer P
Autor:
Giordano Nicoletti, Patrizia Nanni, Marianna L. Ianzano, Morten Nielsen, Jessica Pihl, Thor G. Theander, Adam F. Sander, Arianna Palladini, Thomas Mandel Clausen, Lorena Landuzzi, Stine B. Clemmensen, Christoph M. Janitzek, Willem A. de Jongh, Tania Balboni, Susan Thrane, Pier Luigi Lollini, Manuel L. Penichet, Veronica Giusti, Ali Salanti
Publikováno v:
Oncoimmunology
OncoImmunology, Vol 7, Iss 3 (2018)
OncoImmunology, Vol 7, Iss 3 (2018)
Overexpression of human epidermal growth factor receptor-2 (HER2) occurs in 20–30% of invasive breast cancers. Monoclonal antibody therapy is effective in treating HER2-driven mammary carcinomas, but its utility is limited by high costs, side effec
Autor:
Serenella M. Pupa, Patrizia Nanni, Marianna L. Ianzano, Alessia Lamolinara, Roberta Laranga, Augusto Amici, Veronica Giusti, Pier Luigi Lollini, Arianna Palladini, Tania Balboni, Manuela Iezzi, Giordano Nicoletti, Carla De Giovanni, Lorena Landuzzi, Massimiliano Dall'Ora
Publikováno v:
Cancer Research. 76:1200-1200
Human breast cancer cells express full-length HER-2 along with proteins resulting from mutation, alternative splicing, alternative initiation of translation and post-translational modification. The Delta16 splice variant, lacking exon 16, has the pro
Autor:
Serenella M. Pupa, Pier Luigi Lollini, Marianna L. Ianzano, Dario Ranieri, Augusto Amici, Manuela Iezzi, Lorena Landuzzi, Giordano Nicoletti, Massimiliano Dall'Ora, Roberta Laranga, Patrizia Nanni, Arianna Palladini, Carla De Giovanni, Tania Balboni, Valentina Grosso
Publikováno v:
Cancer Research. 74:2774-2774
HER-2 gene products found in human breast cancer include the full-length p185 oncoprotein and various shorter isoforms that lack C-terminal, N-terminal or internal portions. Delta16 isoform lacks exon 16 and displays the properties of an activated on